Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 501–600 of 1,003
A framework for real‐time glycosylation monitoring (RT‐GM) in mammalian cell culture
Tharmalingam, T., Wu, C., Callahan, S., & T. Goudar, C. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25520 · Cited by 58
de Haan, N., Reiding, K. R., Krištić, J., Ederveen, A. L. H., Lauc, G., & Wuhrer, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00608 · Cited by 67
Analysis of Glycopeptides Using Lectin Affinity Chromatography with MALDI-TOF Mass Spectrometry
Kubota, K., Sato, Y., Suzuki, Y., Goto‐Inoue, N., Toda, T., Suzuki, M., Hisanaga, S., Suzuki, A., & Endo, T. (2008) · Analytical Chemistry · doi:10.1021/ac800070d · Cited by 60
FcγRIIB as a modulator of autoimmune disease susceptibility
Tarasenko, T., Dean, J. A., & Bolland, S. M. (2007) · Autoimmunity · doi:10.1080/08916930701464665 · Cited by 60
Therapeutic Monoclonal Antibodies
Yamada, T. (2011) · The Keio Journal of Medicine · doi:10.2302/kjm.60.37 · Cited by 78
Fc Glycan-Modulated Immunoglobulin G Effector Functions
Quast, I., & Lünemann, J. D. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0018-3 · Cited by 61
Tamminga, R., Berchtold, W., Bruin, M. C. A., Buchanan, G. R., & Kühne, T. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07743.x · Cited by 57
Jones, M. B., Nasirikenari, M., Lugade, A. A., Thanavala, Y. M., & Lau, J. T. Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345710 · Cited by 56
High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases
Ishii, N., Hashimoto, T., Zillikens, D., & Ludwig, R. J. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8153-y · Cited by 56
Kumpel, B. M. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03735.x · Cited by 57
Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery
Ge, S., Wang, Y., Song, M., Li, X., Yu, X., Wang, H., Wang, J., Zeng, Q., & Wang, W. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0053 · Cited by 60
Chandler, K. B., Mehta, N., Leon, D. R., Suscovich, T. J., Alter, G., & Costello, C. E. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001185 · Cited by 60
Khoder‐Agha, F., & Kietzmann, T. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101888 · Cited by 59
Nightingale, T. D., Frayne, M. E. F., Clasper, S., Banerji, S., & Jackson, D. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805105200 · Cited by 56
Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis
Ammirati, E., Bizzi, E., Veronese, G., Groh, M., Heyning, C. M. V. D., Lehtonen, J. Y. A., de Chambrun, M. P., Cereda, A. F., Picchi, C., Trotta, L., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.838564 · Cited by 69
Mastrángelo, A., Colasanti, T., Barbati, C., Pecani, A., Sabatinelli, D., Pendolino, M., Truglia, S., Massaro, L., Mancini, R., Miranda, F., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/712490 · Cited by 64
Mechanisms of Action of Ig Preparations: Immunomodulatory and Anti-Inflammatory Effects
Matucci, A., Maggi, E., & Vultaggio, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00690 · Cited by 57
Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions
Hod, E. A., Cadwell, C. M., Liepkalns, J. S., Zimring, J. C., Sokol, S. A., Schirmer, D. A., Jhang, J. S., & Spitalnik, S. L. (2008) · Blood · doi:10.1182/blood-2008-01-132092 · Cited by 54
Human DC-SIGN and CD23 do not interact with human IgG
Temming, A. R., Dekkers, G., van de Bovenkamp, F. S., Plomp, H. R., Bentlage, A. E. H., Szittner, Z., Derksen, N. I. L., Wuhrer, M., Rispens, T., & Vidarsson, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-46484-2 · Cited by 59
Yamaguchi, Y., & Barb, A. W. (2019) · Glycobiology · doi:10.1093/glycob/cwz068 · Cited by 62
Li, C., Zhu, S., Ma, C. D., & Wang, L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07906 · Cited by 62
Wuhrer, M., Stavenhagen, K., Koeleman, C. A. M., Selman, M. H. J., Harper, L., Jacobs, B. C., Savage, C. O. S., Jefferis, R., Deelder, A. M., & Morgan, M. D. (2015) · Journal of Proteome Research · doi:10.1021/pr500780a · Cited by 61
Gardinassi, L. G., Dotz, V., Ederveen, A. L. H., de Almeida, R. P., Costa, C. H. N., Costa, D. L., de Jesus, A. R., Mayboroda, O. A., Garcia, G. R., Wuhrer, M., et al. (2014) · mBio · doi:10.1128/mbio.01844-14 · Cited by 62
A Perspective on the Structure and Receptor Binding Properties of Immunoglobulin G Fc
Hanson, Q., & Barb, A. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00299 · Cited by 68
Katoh, H., Komura, D., Konishi, H., Suzuki, R. H., Yamamoto, A., Kakiuchi, M., Sato, R., Ushiku, T., Yamamoto, S., Tatsuno, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.016 · Cited by 60
Dimachkie, M. M., Barohn, R. J., & Katz, J. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.01.001 · Cited by 53
Zhang, P., Haryadi, R., Chan, K. F., Teo, G., Goh, J. S. Y., Pereira, N. A., Feng, H., & Song, Z. (2012) · Glycobiology · doi:10.1093/glycob/cws064 · Cited by 52
Wang, L., Norris, E. T., & Jordan, I. K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01418 · Cited by 57
Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development
Kdimati, S., Mullins, C. S., & Linnebacher, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111597 · Cited by 57
Regulatory B Cells: An Exciting Target for Future Therapeutics in Transplantation
Nouël, A., Simon, Q., Jamin, C., Pers, J., & Hillion, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00011 · Cited by 61
The pro and anti-inflammatory activities of immunoglobulin G
Lux, A., Aschermann, S., Biburger, M., & Nimmerjahn, F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117101 · Cited by 52
Self-citationCDG and immune response: From bedside to bench and back
Pascoal, C., Francisco, R., Ferro, T., Ferreira, V. D. R., Jaeken, J., & Videira, P. A. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12126 · Cited by 57
On enzymatic remodeling of IgG glycosylation; unique tools with broad applications
Sjögren, J., Lood, R., & Naegeli, A. (2019) · Glycobiology · doi:10.1093/glycob/cwz085 · Cited by 54
Glycans in Immunologic Health and Disease
Zhou, J. Y., & Cobb, B. A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-074237 · Cited by 58
COVID-19: Infection or Autoimmunity
Icenogle, T. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02055 · Cited by 54
Fang, J. S., Richardson, J., Du, Z., & Zhang, Z. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01323 · Cited by 55
Multiple Roles of Glycans in Hematological Malignancies
Pang, X., Li, H., Guan, F., & Li, X. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00364 · Cited by 60
Gavrović-Jankulović, M. Đ., Poulsen, K., Brckalo, T., Bobic, S., Lindner, B., & Petersen, A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.033 · Cited by 51
Serrato, J. A., Hernandez, V. A., Estrada‐Mondaca, S., Palomares, L. A., & Ramírez, O. T. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060216 · Cited by 57
New Insights into Adaptive Immunity in Chronic Neuroinflammation
Siffrin, V., Brandt, A. U., Herz, J., & Zipp, F. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96001-0 · Cited by 58
Kaufman, G., Massoud, A. H., Dembele, M., Yona, M., Piccirillo, C. A., & Mazer, B. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00469 · Cited by 59
Prophylactic anti‐ D preparations display variable decreases in F c‐fucosylation of anti‐ D
Kapur, R., Valle, L. D., Verhagen, O. J. H. M., Ederveen, A. L. H., Ligthart, P. C., de Haas, M., Kumpel, B. M., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G. (2014) · Transfusion · doi:10.1111/trf.12880 · Cited by 55
Huang, W., Li, J., & Wang, L. (2011) · ChemBioChem · doi:10.1002/cbic.201000763 · Cited by 50
Transient Production of Recombinant Pharmaceutical Proteins in Plants: Evolution and Perspectives
Kopertekh, L., & Schiemann, J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170718114724 · Cited by 50
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors
Corrales‐Aguilar, E., Trilling, M., Reinhard, H., Mercé-Maldonado, E., Widera, M., Schaal, H., Zimmermann, A., Mandelboim, O., & Hengel, H. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.09.006 · Cited by 57
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
Gunn, B. M., Schneider, J. R., Shansab, M., Bastian, A. R., Fahrbach, K. M., Smith, A. D., Mahan, A. E., Karim, M. M., Licht, A. F., Zvonar, I., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.8 · Cited by 56
Schwab, I., & Nimmerjahn, F. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12527 · Cited by 54
Self-citationKurniyati, K., Zhang, W., Zhang, K., & Li, C. (2013) · Molecular Microbiology · doi:10.1111/mmi.12311 · Cited by 54
de Melo, I. S., Grassi, P., Ochoa, F., Bolı́var, J., Garcia-Cozar, F. J., & Durán-Ruiz, M. C. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.012 · Cited by 51
Beyond CA125: The Coming of Age of Ovarian Cancer Biomarkers
Sasaroli, D., Coukos, G., & Scholler, N. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.21 · Cited by 50
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Le, N. P. L., Bowden, T. A., Struwe, W. B., & Crispin, M. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.016 · Cited by 49
Vadrevu, S. K., Trbojević‐Akmačić, I., Kossenkov, A. V., Colomb, F., Giron, L. B., Anzurez, A., Lynn, K., Mounzer, K., LANDAY, A. L., Kaplan, R. C., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi1217-500r · Cited by 50
Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study
Hou, H., Yang, H., Liu, P., Huang, C., Wang, M., Li, Y., Zhu, M., Wang, J., Xu, Y., Wang, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748566 · Cited by 56
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Loeffler, D. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-70 · Cited by 48
Role of N-Glycosylation in FcγRIIIa interaction with IgG
Coillie, J. V., Schulz, M. A., Bentlage, A. E. H., de Haan, N., Ye, Z., Geerdes, D. M., van Esch, W. J. E., Hafkenscheid, L., Miller, R. L., Narimatsu, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.987151 · Cited by 59
Klepach, T. E., Carmichael, I., & Serianni, A. S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja077565g · Cited by 48
Scanlan, C. N., Burton, D. R., & Dwek, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801192105 · Cited by 59
Glycan Biomarkers for Rheumatoid Arthritis and Its Remission Status in Han Chinese Patients
Sebastian, A., Alzain, M. A., Asweto, C. O., Song, H., Cui, L., Yu, X., Ge, S., Dong, H., Rao, P., Wang, H., et al. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0050 · Cited by 54
Chung, C., Wang, Q., Yang, S., Yin, B., Zhang, H., & Betenbaugh, M. (2017) · Biotechnology Journal · doi:10.1002/biot.201600502 · Cited by 48
Abberant Immunoglobulin G Glycosylation in Rheumatoid Arthritis by LTQ-ESI-MS
Su, Z., Xie, Q., Wang, Y., & Li, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062045 · Cited by 56
The Golgi CMP-sialic acid transporter: A new CHO mutant provides functional insights
Lim, S. F., Lee, M. M., Zhang, P., & Song, Z. (2008) · Glycobiology · doi:10.1093/glycob/cwn080 · Cited by 48
Treatment of systemic lupus erythematosus: new advances in targeted therapy
Lo, M. S., & Tsokos, G. C. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06263.x · Cited by 50
Memory Alloreactive B Cells and Alloantibodies Prevent Anti-CD154-Mediated Allograft Acceptance
Burns, A. M., Ma, L., Li, Y., Yin, D., Shen, J., Xu, J., & Chong, A. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1314 · Cited by 47
Ho, C.-H., Chien, R., Cheng, P., Liu, J.-H., Liu, C., Su, C.-S., Wu, I., Li, I.-C., Tsai, H., Wu, S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu388 · Cited by 53
Mauko, L., Nordborg, A., Hutchinson, J. P., Lacher, N. A., Hilder, E. F., & Haddad, P. R. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.09.035 · Cited by 50
Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases
Smarr, C. B., Bryce, P. J., & Miller, S. D. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007046 · Cited by 56
Prislovsky, A., Marathe, B. M., Hosni, A., Bolen, A. L., Nimmerjahn, F., Jackson, C. W., Weiman, D. S., & Strom, T. S. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.12.019 · Cited by 47
Self-citationModulation of mAb quality attributes using microliter scale fed‐batch cultures
Rouiller, Y., Périlleux, A., Vesin, M., Stettler, M., Jordan, M., & Broly, H. (2014) · Biotechnology Progress · doi:10.1002/btpr.1921 · Cited by 53
Controlling the time evolution of mAb N‐linked glycosylation, Part I: Microbioreactor experiments
Villiger, T. K., Roulet, A., Périlleux, A., Stettler, M., Broly, H., Morbidelli, M., & Soos, M. (2016) · Biotechnology Progress · doi:10.1002/btpr.2305 · Cited by 47
Bosseboeuf, A., Allain‐Maillet, S., Mennesson, N., Tallet, A., Rossi, C., Garderet, L., Caillot, D., Moreau, P., Piver, É., Girodon, F., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01347 · Cited by 50
Impact of Fc N-glycan sialylation on IgG structure
Zhang, Z., Shah, B., & Richardson, J. (2019) · mAbs · doi:10.1080/19420862.2019.1655377 · Cited by 46
Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity
Wolf, B., Piksa, M., Beley, I., Patoux, A., Besson, T., Cordier, V., Voedisch, B., Schindler, P. A., Stöllner, D., Perrot, L., et al. (2022) · Immunology · doi:10.1111/imm.13481 · Cited by 48
Schwab, I., Lux, A., & Nimmerjahn, F. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.013 · Cited by 51
Self-citationMechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Tackenberg, B., Nimmerjahn, F., & Lünemann, J. D. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9398-1 · Cited by 48
Self-citationGlycan modulation and sulfoengineering of anti–HIV-1 monoclonal antibody PG9 in plants
Loos, A., Gach, J. S., Hackl, T., Maresch, D., Henkel, T., Porodko, A., Minh, D. B., Sommeregger, W., Wozniak‐Knopp, G., Forthal, D. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509090112 · Cited by 51
Engineered IgG1‐Fc – one fragment to bind them all
Laurent, E., Traxlmayr, M. W., Obinger, C., & Hasenhindl, C. (2016) · Immunological Reviews · doi:10.1111/imr.12385 · Cited by 51
Kao, D., Lux, A., Schaffert, A., Lang, R., Altmann, F., & Nimmerjahn, F. (2017) · European Journal of Immunology · doi:10.1002/eji.201747208 · Cited by 48
Self-citationBlondeel, E. J. M., & Aucoin, M. G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.06.008 · Cited by 46
IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?
Kronimus, Y., Dodel, R. C., Galuska, S. P., & Neumann, S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.006 · Cited by 52
The immunoglobulin-binding Eib proteins from Escherichia coli are receptors for IgG Fc
Leo, J. C., & Goldman, A. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.024 · Cited by 46
Improved mouse models for the study of treatment modalities for immune‐mediated platelet destruction
Katsman, Y., Foo, A. H., Leontyev, D., & Branch, D. R. (2010) · Transfusion · doi:10.1111/j.1537-2995.2009.02558.x · Cited by 46
Widiapradja, A., Vegh, V., Lok, K. Z., Manzanero, S., Thundyil, J., Gelderblom, M., Cheng, Y., Pavlovski, D., Tang, S., Jo, D., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07754.x · Cited by 47
Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells
Edri‐Brami, M., Rosental, B., Hayoun, D., Welt, M., Rosen, H., Wirguin, I., Nefussy, B., Drory, V. E., Porgador, A., & Lichtenstein, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035772 · Cited by 49
Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases
Imbach, P. A. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13593 · Cited by 47
van Berkel, P. H. C., Gerritsen, J., van Voskuilen, E., Perdok, G. J., Vink, T., van de Winkel, J. G. J., & Parren, P. W. H. I. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22535 · Cited by 53
Evolution of sialic acids: implications in xenotransplant biology
Paul, A., & Padler‐Karavani, V. (2018) · Xenotransplantation · doi:10.1111/xen.12424 · Cited by 40
Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
Fang, Q., Ou, J., & Nandakumar, K. S. (2019) · Mediators of Inflammation · doi:10.1155/2019/6363086 · Cited by 52
Carillo, S., Pérez-Robles, R., Jakes, C., da Silva, M. R., Millán‐Martín, S., Farrell, A., Navas, N., & Bones, J. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2019.11.008 · Cited by 48
Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases
Li, D., Lou, Y., Zhang, Y., Liu, S., Li, J., & Tao, J. (2021) · Theranostics · doi:10.7150/thno.53961 · Cited by 48
Plant glycoengineering for designing next-generation vaccines and therapeutic proteins
Strasser, R. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108197 · Cited by 50
Successful Treatment of Necrobiotic Xanthogranuloma With Intravenous Immunoglobulin
Hallermann, C. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.236 · Cited by 44
Lin, J. H., Tan, Q., & Wang, S. (2011) · Journal of Separation Science · doi:10.1002/jssc.201100067 · Cited by 44
Genetic Characteristics and Pathogenic Mechanisms of Periodontal Pathogens
Amano, A., Chen, C., Honma, K., Li, C., Settem, R. P., & Sharma, A. (2014) · Advances in Dental Research · doi:10.1177/0022034514526237 · Cited by 59
Li, H., Gao, W., Feng, X., Liu, B., & Liu, X. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.04.023 · Cited by 43
Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity
Vicente, M. M., Alves, I., Gaifem, J., Rodrigues, C. S., Fernandes, Â., Dias, A. M., Štambuk, J., Pribić, T., Oliveira, P., Ferreira‐da‐Silva, F., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202149491 · Cited by 51
Heemskerk, A. A. M., Wuhrer, M., Busnel, J., Koeleman, C. A. M., Selman, M. H. J., Vidarsson, G., Kapur, R., Schoenmaker, B., Derks, R. J. E., Deelder, A. M., et al. (2013) · ELECTROPHORESIS · doi:10.1002/elps.201200357 · Cited by 43
Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice
Dekkers, G., Bentlage, A. E. H., Plomp, R., Visser, R., Koeleman, C. A. M., Beentjes, A., Mok, J. Y., van Esch, W. J. E., Wuhrer, M., Rispens, T., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.006 · Cited by 49
Sun, S.-J., Tang, Y.-H., Fu, Q., Liu, X., Guo, L., Zhao, Y.-D., & Chang, C.-R. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.02.028 · Cited by 41
Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation
McDonald, A. G., Hayes, J. M., Bezak, T., Gluchowska, S. A., Cosgrave, E. F. J., Struwe, W. B., Stroop, C. J. M., Kok, H. J., van de Laar, T., Rudd, P. M., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.151878 · Cited by 49
Identification of novel plasma glycosylation-associated markers of aging
Catera, M., Borelli, V., Malagolini, N., Chiricolo, M., Venturi, G., Reis, C. A., Osório, H., Abruzzo, P. M., Capri, M., Monti, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7059 · Cited by 49
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.